Cargando…
Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus
Background: Insulin resistance as assessed using homeostasis model assessment ratio (HOMA-R) is associated with latent myocardial damage in apparently healthy subjects in health check. Meanwhile, diabetes mellitus (DM) is an unfavorable prognostic risk factor in patients with heart failure (HF). We...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889481/ https://www.ncbi.nlm.nih.gov/pubmed/33693147 http://dx.doi.org/10.1253/circrep.CR-19-0033 |
_version_ | 1783652318802083840 |
---|---|
author | Narumi, Taro Watanabe, Tetsu Kato, Shigehiko Tamura, Harutoshi Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Shishido, Tetsuro Watanabe, Masafumi |
author_facet | Narumi, Taro Watanabe, Tetsu Kato, Shigehiko Tamura, Harutoshi Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Shishido, Tetsuro Watanabe, Masafumi |
author_sort | Narumi, Taro |
collection | PubMed |
description | Background: Insulin resistance as assessed using homeostasis model assessment ratio (HOMA-R) is associated with latent myocardial damage in apparently healthy subjects in health check. Meanwhile, diabetes mellitus (DM) is an unfavorable prognostic risk factor in patients with heart failure (HF). We examined the impact of pancreatic β-cell dysfunction on clinical outcomes in HF patients without DM. Methods and Results: This study enrolled 312 HF patients without DM. Pancreatic β-cell dysfunction was defined as HOMA-β <30%. A total of 108 patients (35%) had β-cell dysfunction. Plasma brain natriuretic peptide was higher in patients with pancreatic β-cell dysfunction compared with those without (625.2 vs. 399.0 pg/mL, P<0.001). On Kaplan-Meier analysis, a significantly higher cardiovascular events rate was observed in patients with pancreatic β-cell dysfunction (log-rank test, P=0.001), but there was no significant difference between patients with and without insulin resistance. On Cox hazard analysis, pancreatic β-cell dysfunction was independently associated with cardiovascular events after adjustment for confounding factors (HR, 1.58; 95% CI: 1.02–2.45), whereas insulin resistance was not associated with cardiovascular events. Conclusions: Pancreatic β-cell dysfunction, but not insulin resistance, was associated with unfavorable outcome in HF patients without DM. |
format | Online Article Text |
id | pubmed-7889481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Japanese Circulation Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78894812021-03-09 Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus Narumi, Taro Watanabe, Tetsu Kato, Shigehiko Tamura, Harutoshi Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Shishido, Tetsuro Watanabe, Masafumi Circ Rep Original article Background: Insulin resistance as assessed using homeostasis model assessment ratio (HOMA-R) is associated with latent myocardial damage in apparently healthy subjects in health check. Meanwhile, diabetes mellitus (DM) is an unfavorable prognostic risk factor in patients with heart failure (HF). We examined the impact of pancreatic β-cell dysfunction on clinical outcomes in HF patients without DM. Methods and Results: This study enrolled 312 HF patients without DM. Pancreatic β-cell dysfunction was defined as HOMA-β <30%. A total of 108 patients (35%) had β-cell dysfunction. Plasma brain natriuretic peptide was higher in patients with pancreatic β-cell dysfunction compared with those without (625.2 vs. 399.0 pg/mL, P<0.001). On Kaplan-Meier analysis, a significantly higher cardiovascular events rate was observed in patients with pancreatic β-cell dysfunction (log-rank test, P=0.001), but there was no significant difference between patients with and without insulin resistance. On Cox hazard analysis, pancreatic β-cell dysfunction was independently associated with cardiovascular events after adjustment for confounding factors (HR, 1.58; 95% CI: 1.02–2.45), whereas insulin resistance was not associated with cardiovascular events. Conclusions: Pancreatic β-cell dysfunction, but not insulin resistance, was associated with unfavorable outcome in HF patients without DM. The Japanese Circulation Society 2019-05-29 /pmc/articles/PMC7889481/ /pubmed/33693147 http://dx.doi.org/10.1253/circrep.CR-19-0033 Text en Copyright © 2019, THE JAPANESE CIRCULATION SOCIETY This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Original article Narumi, Taro Watanabe, Tetsu Kato, Shigehiko Tamura, Harutoshi Nishiyama, Satoshi Takahashi, Hiroki Arimoto, Takanori Shishido, Tetsuro Watanabe, Masafumi Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title | Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title_full | Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title_fullStr | Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title_full_unstemmed | Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title_short | Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus |
title_sort | impact of impaired pancreatic β-cell function on cardiovascular prognosis in heart failure patients without diabetes mellitus |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889481/ https://www.ncbi.nlm.nih.gov/pubmed/33693147 http://dx.doi.org/10.1253/circrep.CR-19-0033 |
work_keys_str_mv | AT narumitaro impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT watanabetetsu impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT katoshigehiko impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT tamuraharutoshi impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT nishiyamasatoshi impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT takahashihiroki impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT arimototakanori impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT shishidotetsuro impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus AT watanabemasafumi impactofimpairedpancreaticbcellfunctiononcardiovascularprognosisinheartfailurepatientswithoutdiabetesmellitus |